| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |